Results 261 to 270 of about 3,493,028 (307)
Some of the next articles are maybe not open access.
1979
Those who organized the program for this symposium have, indeed, done a skillful job. Scientific presentations on previous days focused attention on exciting new technologies and their obvious- utilities. Speakers and discussants led us onto a mountain of expectation.
openaire +1 more source
Those who organized the program for this symposium have, indeed, done a skillful job. Scientific presentations on previous days focused attention on exciting new technologies and their obvious- utilities. Speakers and discussants led us onto a mountain of expectation.
openaire +1 more source
2020
Assessing benefit in PoTS can be complex as it is defined not only on the basis of a postural heart rate change but also on symptoms. Symptoms may vary with time which adds complexity. Purely basing an assessment on a postural heart change does not provide the full picture however currently there are no validated questionnaires to assess for symptom ...
openaire +1 more source
Assessing benefit in PoTS can be complex as it is defined not only on the basis of a postural heart rate change but also on symptoms. Symptoms may vary with time which adds complexity. Purely basing an assessment on a postural heart change does not provide the full picture however currently there are no validated questionnaires to assess for symptom ...
openaire +1 more source
[Benefit assessment of drugs].
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2017In Germany, new drugs are subject to a benefit assessment at the time of their market access. This "early benefit assessment" is the method primarily used for the benefit assessment of pharmaceuticals in Germany. While for the authorization of a drug a positive risk-benefit ratio is sufficient, early benefit assessment examines whether the new drug has
Thomas, Kaiser +2 more
openaire +1 more source
Enhancing global access to cancer medicines
Ca-A Cancer Journal for Clinicians, 2020Javier Cortes +2 more
exaly
Current treatment and future directions in the management of anal cancer
Ca-A Cancer Journal for Clinicians, 2022Leila T Tchelebi +2 more
exaly